Summary of Product Characteristics
last updated on the eMC:
13/10/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 13/10/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 01-Mar-2011 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change of address details for MAH
|
|
Updated on 03/12/2009 and displayed until 13/10/2011
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
|
| Date of revision of text on the SPC: 01-Sep-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| In section 4.3 (Contraindications), Coal tar should not be used in sore, acute or pustular psoriasis or in the presence of infection added.
|
|
Updated on 19/05/2009 and displayed until 03/12/2009
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
| Date of revision of text on the SPC: |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
